You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

salvage%20autologous%20hematopoietic%20cell%20transplantation

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Precursor Cell Lymphoblastic Leukemia-Lymphoma Trial in Moscow (Autologous HSCT)

Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Autologous HSCT
  • Moscow, Russian Federation
    National Research Center for Hematology
Mar 12, 2018

Prostate Carcinoma, Castration-resistant Prostate Cancer, Circulating Tumor Cells Trial in France (Cabazitaxel, Docetaxel)

Completed
  • Prostate Carcinoma
  • +3 more
  • Angers, France
  • +4 more
Feb 9, 2022

Anatomical Location and Metastasis Pattern of Intrapulmonary

Not yet recruiting
  • Carcinoma
  • Non-small Cell Lung Cancer
  • pulmonary lobectomy
  • (no location specified)
Oct 24, 2021

Head and Neck Squamous Cell Carcinoma, Skin Cancer, Metastatic Head-and-neck Squamous-cell Carcinoma Trial in Jerusalem

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Jerusalem, Israel
    Sharett institute, Hadassah University Hospital - Ein-Kerem
Nov 8, 2021

Carcinoma, Non-Small Cell Lung Trial in Netherlands (carboplatin, paclitaxel, Bevacizumab)

Active, not recruiting
  • Carcinoma, Non-Small Cell Lung
  • Amsterdam, Noord-Holland, Netherlands
  • +27 more
Dec 6, 2021

Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Allogeneic HCT
  • Consolidation chemotherapy
  • Charlotte, North Carolina
    Levine Cancer Institute
Apr 19, 2022

Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in United States (PBCAR0191, Fludarabine, Cyclophosphamide)

Recruiting
  • Non-Hodgkin Lymphoma
  • B-cell Acute Lymphoblastic Leukemia
  • PBCAR0191
  • +2 more
  • Duarte, California
  • +9 more
Apr 18, 2022

Metastatic NSCLC Trial in France (UCPVax)

Active, not recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Besancon, France
  • +4 more
Sep 22, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Metastatic Castration-resistant Prostate Cancer Trial (Pembrolizumab, Enzalutamide)

Completed
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Aug 16, 2022

Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy

Enrolling by invitation
  • Fanconi Anemia Complementation Group A
  • Fanconi Anemia
  • Safety and efficacy assessments
  • Madrid, Spain
    Hospital Infantil Universitario Niño Jesús (HIUNJ)
Jun 18, 2020

Hydroxychloroquine, Gemcitabine, Lung Tumors Trial (Hydroxychloroquine Combined With Gemcitabine)

Not yet recruiting
  • Hydroxychloroquine
  • +2 more
  • Hydroxychloroquine Combined With Gemcitabine
  • (no location specified)
Dec 3, 2022

Prostate Cancer Trial in Charlottesville, Norton, Richmond (Hypofractionated therapy)

Completed
  • Prostate Cancer
  • Hypofractionated therapy
  • Charlottesville, Virginia
  • +2 more
Apr 26, 2021

Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab, paclitaxel, docetaxel)

Completed
Has Results
  • Esophageal Carcinoma
  • Esophagogastric Junction Carcinoma
  • pembrolizumab
  • +3 more
  • (no location specified)
May 5, 2022

Totally Extraperitoneal Repair of Groin Hernia in Liver

Recruiting
  • Liver Transplant Disorder
  • +2 more
  • Totally Extraperitoneal Groin Hernia Repair
  • Barcelona, Spain
    Hospital Clinic of Barcelona
May 12, 2022

Paternal Age and Fetal Aneuploidy

Active, not recruiting
  • Trisomy 21
  • Optimo prenatal screening test
  • Montréal, Quebec, Canada
    Clinique Ovo
Aug 7, 2023

Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston

Terminated
Has Results
  • Resectable Lung Non-Small Cell Carcinoma
  • +10 more
  • Bintrafusp Alfa
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jul 27, 2022

Acute Myelogenous Leukemia, MDS, Mixed Phenotype Acute Leukemia Trial (Fludarabine, Cytarabine, Uproleselan)

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +2 more
  • (no location specified)
Mar 3, 2022

Sickle Cell Anemia Trial in Worldwide (ACZ885, Placebo)

Completed
Has Results
  • Sickle Cell Anemia
  • Atlanta, Georgia
  • +14 more
Oct 7, 2021

Hematopoietic Stem Cell Transplantation, Antithymocyte Globulin, Viral Infection Trial in Guangzhou (ATG)

Completed
  • Hematopoietic Stem Cell Transplantation
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Apr 21, 2018

Esophageal Tumors Trial in Shantou (SMART, PF)

Completed
  • Esophageal Neoplasms
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Dec 27, 2021

Influenza, Human, Infections, Respiratory Tract Infections Trial in United States (aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on

Not yet recruiting
  • Influenza, Human
  • +4 more
  • aH5N8c on Day 1
  • +4 more
  • Cullman, Alabama
  • +8 more
May 15, 2023

Poliomyelitis Trial in Geelong, Melbourne (Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio), Inactivated

Not yet recruiting
  • Poliomyelitis
  • Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio)
  • +3 more
  • Geelong, Victoria, Australia
  • +1 more
Oct 30, 2023

Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,

Active, not recruiting
  • Colorectal Adenocarcinoma
  • +14 more
  • Atlanta, Georgia
  • +2 more
Jul 5, 2022